Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Susan C, Charman"'
Autor:
Gemma E. Stanford, Mandy Jones, Susan C. Charman, Diana Bilton, Omar S. Usmani, Jane C. Davies, Nicholas J. Simmonds
Publikováno v:
Therapeutic Advances in Respiratory Disease, Vol 16 (2022)
Background: Airway clearance techniques (ACTs) are integral to cystic fibrosis (CF) management. However, there is no consensus as to which outcome measures (OMs) are best for assessing ACT efficacy. Objectives: To summarise OMs that have been assesse
Externí odkaz:
https://doaj.org/article/1935b98869e14fbfa892edc1a5075e54
Autor:
null Gemma E. Stanford, null Mandy Jones, null Susan C. Charman, null Diana Bilton, null Omar S. Usmani, null Jane C. Davies, null Nicholas J. Simmonds
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8638477dbcf888ed77086c2c26f4903
https://doi.org/10.1177/17534666221122572/v2/response1
https://doi.org/10.1177/17534666221122572/v2/response1
Autor:
David Eldred-Evans, Alex Freeman, Lucy A.M. Simmons, Joana B. Neves, Caroline M. Moore, Manit Arya, Susan C. Charman, Abi Kanthabalan, Hashim U. Ahmed, Shonit Punwani, Mark Emberton, Neil McCartan, Taimur T. Shah
Publikováno v:
BJU International. 125:391-398
Objective To determine the additional diagnostic value of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced imaging (DCE) in men requiring a repeat biopsy within the PICTURE study. Patients and methods PICTURE was a paired-cohort confirm
Autor:
Jan van der Meulen, Heather Payne, Noel W. Clarke, Julie Nossiter, Arunan Sujenthiran, Thomas E Cowling, Matthew G. Parry, Susan C. Charman, Ajay Aggarwal
Publikováno v:
Cancer Epidemiology. 58:44-51
Background Cancer stage can be missing in national cancer registry records. We explored whether missing prostate cancer stage can be imputed using specific clinical assumptions. Methods Prostate cancer patients diagnosed between 2010 and 2013 were id
Autor:
Maya Desai, Chris Hine, Joanna L. Whitehouse, Keith Brownlee, Susan C. Charman, Prasad Nagakumar
Publikováno v:
Respiratory Medicine. 199:106878
The availability of mutation-specific cystic fibrosis modulator therapies has the potential to improve the lives of children and adults with cystic fibrosis. The frequency of mutations causing defects in the cystic fibrosis transmembrane conductance
Autor:
Omar S. Usmani, Mandy Jones, Jane C. Davies, Susan C. Charman, Gemma Stanford, Nicholas J. Simmonds, Diana Bilton
Background Airway clearance techniques (ACTs) are integral to cystic fibrosis (CF) management. However, there is no consensus as to which outcome measures (OMs) are best for assessing ACT efficacy. Objectives: To summarise OMs that have been assessed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::49a145ef1acf055a8296c8afd6dcbc79
https://doi.org/10.21203/rs.3.rs-585783/v1
https://doi.org/10.21203/rs.3.rs-585783/v1
Autor:
Ruth H. Keogh, Aliza K. Fink, David Taylor-Robinson, Siobhán B. Carr, Daniela K Schlüter, Albert Faro, Rhonda D. Szczesniak, Susan C. Charman, Bruce C. Marshall, Josh Ostrenga, Christopher H. Goss
Publikováno v:
THORAX
RationaleA previous analysis found significantly higher lung function in the US paediatric cystic fibrosis (CF) population compared with the UK with this difference apparently decreasing in adolescence and adulthood. However, the cross-sectional natu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7e792c5a7ea8a3394af2876b445ce2b
https://researchonline.lshtm.ac.uk/id/eprint/4662941/1/thoraxjnl-2021-216849.full.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4662941/1/thoraxjnl-2021-216849.full.pdf
Autor:
A Lee, Susan C. Charman, Daniel Campbell, Steve Cunningham, Runyu Wu, N. Volkova, Mark Higgins, Alexander Elbert
Publikováno v:
Therapeutic advances in cystic fibrosis: today and tomorrow.
Introduction and Objectives Ivacaftor, a CFTR potentiator, was shown as safe and beneficial over 24 weeks in young children with CF and a gating mutation (Davies JC, et al. Lancet Respir Med. 2016;4:107–15). This prespecified interim analysis of an
Autor:
Mandy Jones, Gemma Stanford, Omar S. Usmani, Nicholas J. Simmonds, Diana Bilton, Winston Banya, Jane C. Davies, Susan C. Charman
Publikováno v:
BMJ Open Respiratory Research
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
BMJ Open Respiratory Research, Vol 7, Iss 1 (2020)
IntroductionAirway clearance techniques (ACTs) are a gold standard of cystic fibrosis management; however, the majority of research evidence for their efficacy is of low standard; often attributed to the lack of sensitivity from outcome measures (OMs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b16db6ddbb091d1f7911fc8d0de7266
http://bura.brunel.ac.uk/handle/2438/21874
http://bura.brunel.ac.uk/handle/2438/21874
Publikováno v:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society. 20(2)
As part of the risk management plan in Europe, a long-term observational study was conducted to monitor the safety of colistimethate sodium dry powder for inhalation (CMS-DPI) compared to other inhaled antibiotics.A cohort of CMS-DPI patients and a m